Repare Therapeutics Inc. (RPTX)
NASDAQ: RPTX · Real-Time Price · USD
2.590
0.00 (0.00%)
Jan 22, 2026, 4:00 PM EST - Market closed
Repare Therapeutics Market Cap
Repare Therapeutics has a market cap or net worth of $111.65 million as of January 23, 2026. Its market cap has increased by 90.32% in one year.
Market Cap
111.65M
Enterprise Value
-611.34K
1-Year Change
90.32%
Ranking
Category
Stock Price
$2.59
Market Cap Chart
Since June 19, 2020, Repare Therapeutics's market cap has decreased from $945.76M to $111.65M, a decrease of -88.19%. That is a compound annual growth rate of -31.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 111.65M | -0.38% |
| Dec 31, 2025 | 112.08M | 101.26% |
| Dec 31, 2024 | 55.69M | -81.89% |
| Dec 29, 2023 | 307.55M | -50.18% |
| Dec 30, 2022 | 617.25M | -29.87% |
| Dec 31, 2021 | 880.19M | -30.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 19, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Agenus | 115.12M |
| Artiva Biotherapeutics | 113.40M |
| Acumen Pharmaceuticals | 112.97M |
| MacroGenics | 110.70M |
| Tharimmune | 109.54M |
| Karyopharm Therapeutics | 108.95M |
| Fortress Biotech | 108.29M |
| Oncolytics Biotech | 105.94M |